Merck and Samsung Bioepsis launched a biosimilar version of Remicade in the U.S. for treating rheumatoid arthritis and Crohn's disease.
↧
STAT Plus Pharmalittle Merck launches a biosimilar Remicade; J&J releases promising HIV vaccine data
↧